Dr. Martens (LON:DOCS) Shares Down 9.6% – Should You Sell?

Dr. Martens plc (LON:DOCS) traded down 9.6% during trading on Thursday . The stock traded as low as GBX 72.30 and last traded at GBX 73.80. 4,733,644 shares changed hands during mid-day trading, an increase of 115% from the average session volume of 2,203,986 shares. The stock had previously closed at GBX 81.60.

Analyst Upgrades and Downgrades

Separately, Peel Hunt reaffirmed a “buy” rating on shares of Dr. Martens in a research note on Thursday. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of GBX 6,000.

Dr. Martens Price Performance

The firm has a market capitalization of £713.15 million, a price-to-earnings ratio of 147.60, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The stock’s fifty day moving average price is GBX 90.64 and its two-hundred day moving average price is GBX 80.35. The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 127.27.

Dr. Martens (LON:DOCS) last announced its quarterly earnings results on Thursday, November 20th. The company reported GBX (0.90) earnings per share (EPS) for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. Equities research analysts expect that Dr. Martens plc will post 2.5809394 EPS for the current year.

Insider Buying and Selling at Dr. Martens

In other Dr. Martens news, insider Ije Nwokori sold 298,675 shares of the firm’s stock in a transaction dated Wednesday, October 15th. The stock was sold at an average price of GBX 90, for a total transaction of £268,807.50. Also, insider Giles Wilson sold 30,000 shares of the business’s stock in a transaction dated Monday, September 1st. The shares were sold at an average price of GBX 91, for a total value of £27,300. Over the last quarter, insiders have purchased 136,960 shares of company stock worth $12,460,163 and have sold 434,460 shares worth $39,131,400. 2.80% of the stock is owned by company insiders.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.